Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2007Pediatric Blood & Cancer

Early relapse after rituximab chemoimmunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

FKFlóra KissHealth Education EnglandJBJúlia BusligUniversity of DebrecenISIstván SzegediUniversity of Debrecen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kiss et al. (2007) studied this question.

synapsesocial.com/papers/6a79748aa51ded8e7b3231fchttps://doi.org/10.1002/pbc.21388
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia2006 · 568 citations
  2. 2Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen2007 · 102 citations
  3. 3Leukemic cells and the cytokine patchwork2003 · 15 citations